David S Jones

Recommendations for the use of clinical outcome assessments in rare disease drug development

Summary There are over 10,000 rare diseases collectively affecting an estimated 250–450 million people globally. While these diseases are rare individually, their cumulative impact on patients, families, healthcare systems, and society is substantial. The incorporation of clinical outcome assessments (COAs) in clinical...